
Cytek Biosciences, Inc.
CTKBNASDAQHealthcareMedical - Devices
Previous close
$4.81
+$0.15 · +3.22%
Pre-market
$4.6909
−$0.1191 · -2.48%
Aug 24, 4:18 AM ET
CTKB company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
50
Neutral
Sentiment
62
Bullish
Risk resilience
45
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteCytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Wenbin Jiang
- Listed since
- Jul 23, 2021
- Employees
- 682
Market position
Day range
Current $4.81
52-week range
Current $4.81
- Open
- $4.64
- Previous close
- $4.66
- Volume
- 820.26K
- 0.69× average
- Average volume
- 1.2M
- Average daily volume
- Market cap
- 621.18M USD
- Beta
- 1.17
- Market reference 1
- 50-day average
- $4.4326
- +8.51% above average
- 200-day average
- $4.6113
- +4.31% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -7.72×
- P/B (TTM)
- 1.93×
- P/S (TTM)
- 3.01×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 53.23%
- Operating margin
- -21.60%
- Net margin
- -38.98%
Financial health
- Debt / equity
- 0.08×
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -143.66%
- 11 comparable reports
- Latest EPS result
- -0.05
- Estimate -0.09 · Beat by 46.43%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$4.88
1.46% upsideRating distribution
5 ratingsCTKB peers
ETFs holding CTKB
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI14.88M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM14.52M0.02%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF5.5M0.01%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN5.28M0.04%14.66B USD0.24%$224.81+0.45%
iShares Biotechnology ETFIBB4.09M0.04%10.75B USD0.44%$213.56+1.29%
Vanguard Russell 2000 ETFVTWO2.89M0.02%17.4B USD0.06%$121.25+0.74%
Fidelity Enhanced Small Cap ETFFESM2.62M0.04%6.03B USD0.28%$47.94+0.80%
Schwab U.S. Small-Cap ETFSCHA2.53M0.01%23.1B USD0.03%$34.83+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 14.88M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 14.52M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 5.5M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 5.28M
- Weight
- 0.04%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
iShares Biotechnology ETFIBB- Market value
- 4.09M
- Weight
- 0.04%
- AUM
- 10.75B USD
- Expense ratio
- 0.44%
- Price / 1D
- $213.56+1.29%
Vanguard Russell 2000 ETFVTWO- Market value
- 2.89M
- Weight
- 0.02%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Fidelity Enhanced Small Cap ETFFESM- Market value
- 2.62M
- Weight
- 0.04%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94+0.80%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 2.53M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Continue in GoAI
Research CTKBresearch.disclaimer





